Haploidentical stem cell transplantation using PTCY for children with acute leukemia Principal investigator Annalisa Ruggeri
Use of eculizumab to treat thrombotic microangiopathy associated with haematopoietic stem cell transplantation - a retrospective study on behalf of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation Diseases Type of transplant Principal investigator Peter Svec
Pregnancy rates and Pregnancy outcomes after hematopoietic stem cell transplantation in childhood Diseases Type of transplant Principal investigator Tamara Diesch-Furlanetto
Retrospective analysis on the outcome of autologous and allogeneic stem cell transplantation in children and adolescents with non-anaplastic peripheral T-cell lymphoma Type of transplant Principal investigator Olga Moser
Haematopoietic stem cell transplantation in children and adolescents with non hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation Type of transplant Principal investigator Laura Alonso
Allogeneic stem cell transplantation for refractory AML: a comparison between sequential or standard myeloablative conditioning regimen (a retrospective study). Principal investigator Audrey Grain
Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation Diseases Principal investigator Fanette Bernard
Haematopoietic stem cell transplantation for sickle cell diseaseAn analysis on behalf of Eurocord, PDWP of EBMT, CIBMTR, USP (Ribeirão Preto) and Ruby Hall Clinic Type of transplant Principal investigator Eliane Gluckman
Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) Principal investigator Sabine BLUM , Yves Chalandon
Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL. Principal investigator Klaus HIRSCHBUEHL
A multi-centre, multinational, prospective observational registry to collect safety and outcome data in patients diagnosed with severe hepatic veno-occlusive disease (VOD) following hematopoietic stem cell transplantation (HSCT) and treated with Defitelio® Principal investigator Pr Mohamad Mohty